{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:05:12Z","timestamp":1780988712871,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Previous studies have reported that long-term use of valproic acid can cause changes in bone metabolism in children. We conducted this meta-analysis to determine the effects of valproic acid on bone metabolism and bone mineral density (BMD) in children with epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Studies were searched from the databases of PubMed, Embase, Ovid, Cochrance Library, Springer Link and Web of Science. The effects of valproic acid on bone metabolism indicators and BMD were assessed through calculating the standardized mean difference (SMD) with 95% confidence interval (CI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen studies with 987 individuals were included in this analysis. The long-term use of valproic acid did not affect the levels of serum calcium (<jats:italic>p<\/jats:italic>\u00a0=\u20090.99), phosphorus (<jats:italic>p<\/jats:italic>\u00a0=\u20090.28), ALP (<jats:italic>p<\/jats:italic>\u00a0=\u20090.76), PTH (<jats:italic>p<\/jats:italic>\u00a0=\u20090.36) and osteocalcin (<jats:italic>p<\/jats:italic>\u00a0=\u20090.72), but it led to a decrease in 25-OH-VitD (<jats:italic>p<\/jats:italic>\u00a0=\u20090.01) and BMD (<jats:italic>p<\/jats:italic>\u00a0=\u20090.002 for the vertebra;<jats:italic>p<\/jats:italic>\u00a0=\u20090.004 for the femur) in treating children with epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Long-term use of valproic acid in treating children with epilepsy can lead to a reduction in 25-OH-VitD and BMD. Measurements of 25-OH-VitD and BMD should be performed regularly in children taking the drug to detect early osteopenia caused by the drug.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-020-1984-7","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T11:03:09Z","timestamp":1583146989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies"],"prefix":"10.1186","volume":"20","author":[{"given":"Li","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chunyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Biaoxue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"issue":"3","key":"1984_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/epi.13294","volume":"57","author":"I Megiddo","year":"2016","unstructured":"Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, Laxminarayan R. Health and economic benefits of public financing of epilepsy treatment in India: an agent-based simulation model. Epilepsia. 2016;57(3):464\u201374.","journal-title":"Epilepsia"},{"issue":"3","key":"1984_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/ijms19030871","volume":"19","author":"Vanessa Lin Lin Lee","year":"2018","unstructured":"Lin Lin Lee V, Kar Meng Choo B, Chung YS, Kundap UP, Kumari Y, Shaikh MF. Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review. Int J Mol Sci. 2018;19(3):871..","journal-title":"International Journal of Molecular Sciences"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","volume":"77","author":"J Vidaurre","year":"2017","unstructured":"Vidaurre J, Gedela S, Yarosz S. Antiepileptic drugs and liver disease. Pediatr Neurol. 2017;77:23\u201336.","journal-title":"Pediatr Neurol"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/479364","volume":"2010","author":"S\u00e9bastien Chateauvieux","year":"2010","unstructured":"Chateauvieux S, Morceau F, Dicato M, Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. 2010;2010:479364.","journal-title":"Journal of Biomedicine and Biotechnology"},{"issue":"Suppl 2","key":"1984_CR5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.yebeh.2003.11.025","volume":"5","author":"RD Sheth","year":"2004","unstructured":"Sheth RD. Bone health in pediatric epilepsy. Epilepsy Behav. 2004;5(Suppl 2):S30\u20135.","journal-title":"Epilepsy Behav"},{"issue":"8","key":"1984_CR6","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/ijms17081242","volume":"17","author":"Hueng-Chuen Fan","year":"2016","unstructured":"Fan HC, Lee HS, Chang KP, Lee YY, Lai HC, Hung PL, Lee HF, Chi CS. The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci. 2016;17(8):1242.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1984_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/jpn.JPN_161_16","volume":"12","author":"B Hasaneen","year":"2017","unstructured":"Hasaneen B, Elsayed RM, Salem N, Elsharkawy A, Tharwat N, Fathy K, El-Hawary A, Aboelenin HM. Bone mineral status in children with epilepsy: biochemical and radiologic markers. J Pediatr Neurosci. 2017;12(2):138\u201343.","journal-title":"J Pediatr Neurosci"},{"issue":"10","key":"1984_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334.","journal-title":"J Clin Epidemiol"},{"key":"1984_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/CLEP.S66677","volume":"6","author":"AV Margulis","year":"2014","unstructured":"Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, Viswanathan M, Perez-Gutthann S. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa scale and the RTI item bank. Clin Epidemiol. 2014;6:359\u201368.","journal-title":"Clin Epidemiol"},{"issue":"48","key":"1984_CR10","doi-asserted-by":"publisher","first-page":"78994","DOI":"10.18632\/oncotarget.12982","volume":"7","author":"R Biaoxue","year":"2016","unstructured":"Biaoxue R, Hua L, Wenlong G, Shuanying Y. Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis. Oncotarget. 2016;7(48):78994\u20139007.","journal-title":"Oncotarget"},{"issue":"2","key":"1984_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0887-8994(98)00039-3","volume":"19","author":"R Akin","year":"1998","unstructured":"Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol. 1998;19(2):129\u201331.","journal-title":"Pediatr Neurol"},{"issue":"9\u201310","key":"1984_CR12","first-page":"703","volume":"24","author":"A Aksoy","year":"2011","unstructured":"Aksoy A, Sonmez FM, Deger O, Hosver I, Karaguzel G. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy. J Pediatr Endocrinol Metab. 2011;24(9\u201310):703\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"1984_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2006.03.004","volume":"35","author":"A Babayigit","year":"2006","unstructured":"Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol. 2006;35(3):177\u201381.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"1984_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1515\/JPEM.2000.13.7.933","volume":"13","author":"E Erbayat Altay","year":"2000","unstructured":"Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000;13(7):933\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"1984_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/00207450290158269","volume":"112","author":"H Caksen","year":"2002","unstructured":"Caksen H, Dulger H, Cesur Y, Odabas D, Tuncer O, Atas B. No effect of long-term valproate therapy on thyroid and parathyroid functions in children. Int J Neurosci. 2002;112(11):1371\u20134.","journal-title":"Int J Neurosci"},{"issue":"4","key":"1984_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2004.03.021","volume":"31","author":"C Ecevit","year":"2004","unstructured":"Ecevit C, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol. 2004;31(4):279\u201382.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"1984_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/000992289903800205","volume":"38","author":"G Kafali","year":"1999","unstructured":"Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila). 1999;38(2):93\u20138.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"1984_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpem-2006-190411","volume":"19","author":"S Kumandas","year":"2006","unstructured":"Kumandas S, Koklu E, Gumus H, Koklu S, Kurtoglu S, Karakukcu M, Keskin M. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab. 2006;19(4):529\u201334.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"1984_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1440-1754.2004.00431.x","volume":"40","author":"N Oner","year":"2004","unstructured":"Oner N, Kaya M, Karasalihoglu S, Karaca H, Celtik C, Tutunculer F. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health. 2004;40(8):470\u20133.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"1984_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12098-014-1518-0","volume":"82","author":"O Yaghini","year":"2015","unstructured":"Yaghini O, Tonekaboni SH, Amir Shahkarami SM, Ahmad Abadi F, Shariat F, Abdollah Gorji F. Bone mineral density in ambulatory children with epilepsy. Indian J Pediatr. 2015;82(3):225\u20139.","journal-title":"Indian J Pediatr"},{"issue":"3","key":"1984_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1469-8749.2009.03402.x","volume":"52","author":"M Rauchenzauner","year":"2010","unstructured":"Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, Falkensammer G, Luef G, Hogler W. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol. 2010;52(3):283\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"1984_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.yebeh.2015.06.025","volume":"51","author":"HM Serin","year":"2015","unstructured":"Serin HM, Koc ZP, Temelli B, Esen I. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine. Epilepsy Behav. 2015;51:221\u20134.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"1984_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/seiz.2002.0671","volume":"11","author":"K Voudris","year":"2002","unstructured":"Voudris K, Moustaki M, Zeis PM, Dimou S, Vagiakou E, Tsagris B, Skardoutsou A. Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy. Seizure. 2002;11(6):377\u201380.","journal-title":"Seizure"},{"issue":"Suppl 1","key":"1984_CR24","first-page":"584","volume":"5","author":"L Ardeshirpour","year":"2007","unstructured":"Ardeshirpour L, Cole DE, Carpenter TO. Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev. 2007;5(Suppl 1):584\u201398.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"1984_CR25","doi-asserted-by":"publisher","first-page":"e22985","DOI":"10.1002\/ajhb.22985","volume":"29","author":"Babette S. Zemel","year":"2017","unstructured":"Zemel BS. Influence of complex childhood diseases on variation in growth and skeletal development. Am J Hum Biol. 2017;29(2). https:\/\/doi.org\/10.1002\/ajhb.22985.","journal-title":"American Journal of Human Biology"},{"issue":"4","key":"1984_CR26","first-page":"186","volume":"55","author":"L Brandi","year":"2008","unstructured":"Brandi L. 1alpha(OH)D3 one-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Dan Med Bull. 2008;55(4):186\u2013210.","journal-title":"Dan Med Bull"},{"key":"1984_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40985-017-0066-3","volume":"38","author":"M Fiscaletti","year":"2017","unstructured":"Fiscaletti M, Stewart P, Munns CF. The importance of vitamin D in maternal and child health: a global perspective. Public Health Rev. 2017;38:19.","journal-title":"Public Health Rev"},{"issue":"6","key":"1984_CR28","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1210\/jc.2002-021614","volume":"88","author":"M Ferin","year":"2003","unstructured":"Ferin M, Morrell M, Xiao E, Kochan L, Qian F, Wright T, Sauer M. Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey. J Clin Endocrinol Metab. 2003;88(6):2908\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1984_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1381612825666190329145428","volume":"25","author":"HL Guo","year":"2019","unstructured":"Guo HL, Jing X, Sun JY, Hu YH, Xu ZJ, Ni MM, Chen F, Lu XP, Qiu JC, Wang T. Valproic acid and the liver injury in patients with epilepsy: an update. Curr Pharm Des. 2019;25(3):343\u201351.","journal-title":"Curr Pharm Des"},{"issue":"9","key":"1984_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/adc.88.9.795","volume":"88","author":"MS Fewtrell","year":"2003","unstructured":"Fewtrell MS. Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child. 2003;88(9):795\u20138.","journal-title":"Arch Dis Child"},{"issue":"12","key":"1984_CR31","doi-asserted-by":"publisher","first-page":"9908","DOI":"10.3390\/nu7125517","volume":"7","author":"V Vera","year":"2015","unstructured":"Vera V, Moran JM, Barros P, Canal-Macias ML, Guerrero-Bonmatty R, Costa-Fernandez C, Lavado-Garcia JM, Roncero-Martin R, Pedrera-Zamorano JD. Greater calcium intake is associated with better bone health measured by quantitative ultrasound of the phalanges in pediatric patients treated with anticonvulsant drugs. Nutrients. 2015;7(12):9908\u201317.","journal-title":"Nutrients"},{"issue":"2","key":"1984_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40272-014-0115-z","volume":"17","author":"P Vestergaard","year":"2015","unstructured":"Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs. 2015;17(2):141\u201350.","journal-title":"Paediatr Drugs"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-020-1984-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T11:53:50Z","timestamp":1722513230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-1984-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-1984-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"20 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval is not required for this review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}